scholarly journals Prevalence of Cigarette Smoking and Nicotine Dependence in Men and Women Residing in Two Provinces in China

2017 ◽  
Vol 8 ◽  
Author(s):  
Yunlong Ma ◽  
Li Wen ◽  
Wenyan Cui ◽  
Wenji Yuan ◽  
Zhongli Yang ◽  
...  
Keyword(s):  
Cigarette Smoking ◽  
Nicotine Dependence ◽  
Men And Women

Abstract P116: Trait Anger Increases Short-term and Long-term Risk for Recurrent CHD: The Atherosclerosis Risk in Communities (ARIC) Study

Circulation ◽  
2013 ◽  
Vol 127 (suppl_12) ◽  
Author(s):  
Janice E Williams ◽  
Sharon B Wyatt ◽  
Kathryn M Rose ◽  
David J Couper ◽  
Anna Kucharska-Newton
Keyword(s):  
Cigarette Smoking ◽  
Trait Anger ◽  
Middle Aged ◽  
Short Term ◽  
Men And Women ◽  
Atherosclerosis Risk In Communities ◽  
Atherosclerosis Risk ◽  
Aric Study

Though several large epidemiologic studies have demonstrated the positive association of anger with coronary heart disease (CHD) onset, a dearth of population-based evidence exists regarding the relationship of anger to the clinical course of CHD among people with established disease. Trait anger is conceptualized as a stable personality trait and defined as the tendency to experience frequent and intense anger. Therefore, it is plausible that the effects of trait anger on CHD are long standing. We assessed the hypothesis that trait anger predicts short-term and long-term risk for recurrent CHD among middle-aged men and women. Participants were 611 black or white men and women, ages 48 - 67, who had a history of CHD at the second clinical examination (1990-1992) of the Atherosclerosis Risk in Communities (ARIC) Study. They were followed for the recurrence of CHD (myocardial infarction or fatal CHD) from 1990 through three different time intervals: 1995, 2003, and 2009 (maximum follow-up = 19.0 years). Trait anger (measured at Visit 2) was assessed using the Spielberger Trait Anger Scale, with scores categorized as high, moderate, and low. Cox proportional hazards regression analyses were adjusted for age, sex, race-center, educational level, waist-to-hip ratio, plasma LDL-and HDL-cholesterol levels, hypertension, diabetes, cigarette smoking status, and pack-years of cigarette smoking. After 3 - 5 years of follow-up, the risk for recurrent CHD among participants with high trait anger was more than twice that of their counterparts with low trait anger (2.24 [95% C.I: 1.14 to 4.40]). After 11 - 13 years, the risk was 80% greater (1.80 [95% C.I: 1.17 to 2.78]) and after 17 - 19 years, it was 70% greater (1.70 [95% C.I: 1.15 to 2.52]). The risk for recurrent CHD was strongest in the first time interval but remained strong and statistically significant through 19 years of follow-up. In conclusion, the experience of frequent and intense anger increases short-term and long-term risk for recurrent CHD in middle-aged men and women.

scholarly journals Frequency of Cigarette Smoking Among Psychiatric Inpatients Evaluated by the Fagerstrom Test for Nicotine Dependence

2013 ◽  
Vol 14 (1) ◽  
pp. 579-582 ◽  
Author(s):  
Ozlem Tanriover ◽  
Nesrin Karamustafalioglu ◽  
Zehra Tezvaran ◽  
Asli Kaplan ◽  
Nesrin Tomruk
Keyword(s):  
Cigarette Smoking ◽  
Nicotine Dependence ◽  
Psychiatric Inpatients

scholarly journals Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: The JPHC study

2002 ◽  
Vol 99 (2) ◽  
pp. 245-251 ◽  
Author(s):  
Tomotaka Sobue ◽  
Seiichiro Yamamoto ◽  
Megumi Hara ◽  
Shizuka Sasazuki ◽  
Satoshi Sasaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cigarette Smoking ◽  
Histologic Type ◽  
Middle Aged ◽  
Japanese Men ◽  
Men And Women ◽  
Subsequent Risk

scholarly journals Cigarette Smoking and Risk of Type 2 Diabetes Mellitus among Middle-aged and Elderly Japanese Men and Women

2004 ◽  
Vol 160 (2) ◽  
pp. 158-162 ◽  
Author(s):  
T. Sairenchi ◽  
H. Iso ◽  
A. Nishimura ◽  
T. Hosoda ◽  
F. Irie ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cigarette Smoking ◽  
Middle Aged ◽  
Japanese Men ◽  
Men And Women ◽  
Elderly Japanese

Effect of smoking cessation with varenicline on blood pressure control in hypertensive patients

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
N Ioakeimidis ◽  
C Georgakopoulos ◽  
E Emmanouil ◽  
I Dima ◽  
E Solomou ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Smoking Cessation ◽  
Cigarette Smoking ◽  
Arterial Hypertension ◽  
Nicotine Dependence ◽  
Self Report ◽  
Time Interval ◽  
Smoking Abstinence ◽  
Diagnosis Of Hypertension

Abstract Purpose The interaction between smoking and blood pressure (BP) is complex. Despite the strong association between cigarette smoking and cardiovascular disease (CVD) risk, there is paucity about the effect of pharmacotherapies for treating tobacco dependence on BP in already established arterial hypertension. Varenicline has been shown to be an effective and well-tolerated pharmaceutical intervention for smoking cessation. Aim of the study was to investigate the improvement in BP control in smokers with a diagnosis of hypertension who quit or reduced substantially their tobacco consumption by using varenicline and the association of nicotine dependence with BP changes. Methods A total of 89 (mean age:48±7, 52 males) regular smokers (28±9 pack-years) with a diagnosis of hypertension and on anti-hypertensive drugs were studied. All patients received low-intensity counseling and pharmacotherapy with varenicline (1 mg twice daily) for 12 weeks. Point prevalence smoking abstinence was defined by self-report of complete abstinence in the 7 days before the 12 week clinic visit (end of therapy). Office BP was measured at baseline and each follow-up visit (4 and 12 weeks) office BP. The Fagerström Test for Nicotine Dependence (FTND) was used for assessing nicotine dependence. High nicotine dependence (ND) was defined as a FTND score ≥6. Results At 12 weeks, 60 (67%) patients were abstinent from smoking and 14 (16%) were non-abstainers who reduced daily consumption to 50% of baseline. The mean time interval between the initiation of treatment with varenicline and smoking abstinence was 1.8±0.6 weeks. There were not significant differences in age, baseline BP level, severity of nicotine dependence and total cigarette consumption (pack-years) between the two groups. Systolic BP (SBP) and diastolic BP (DBP) decreased significantly in abstainers (by 7.2 and 5.5 mmHg at 12 weeks, P<0.01 and P<0.05, respectively) while the decrease in BP level in non-abstainers was minimal. Among patients with sustained tobacco abstinence, 18 were highly ND and 42 had mild and moderate ND. The two ND groups had similar age and BP levels at baseline. Changes in SBP and DBP from baseline in smokers with arterial hypertension between the two ND groups are illustrated in Figure. The observed reductions in SBP and DBP were significant (P<0.05, both for SBP and DBP) when comparing the high ND group to the mild/moderate ND group at 12 weeks. No severe adverse reactions were reported with varenicline use throughout the entire follow-up duration. Conclusion Varenicline may help smokers with arterial hypertension under antihypertensive therapy to remain abstinent from tobacco cigarette smoking. A novel and important message of this study is also the substantial improvements in office SBP and DBP in highly nicotine dependent sustained tobacco abstainers. ND-BP changes after varenicline therapy Funding Acknowledgement Type of funding source: None

Sign in / Sign up

Export Citation Format

Share Document